image

India’s Superbug Crisis Deepens: How Antibiotic Resistance Is Rising at an Alarming Rate in 2025

India’s Superbug Crisis: Antibiotic Resistance Soars in 2025 Antibiotic resistance in India has reached a critical stage, posing a severe threat to public health. Hospitals, clinics, and even households are witnessing stronger and more stubborn bacterial infections that no longer respond to commonly used medicines. This fast-spreading crisis is largely fueled by improper antibiotic usage,…

Read More
image 116

Cipla Launches India’s First Non-Antibiotic Drug HUENA for Recurrent UTI

Cipla has made a groundbreaking move in India’s healthcare sector with the launch of Methenamine Hippurate, a non-antibiotic drug for patients suffering from recurrent Urinary Tract Infections (UTIs), under the brand name HUENA. UTIs are a major health concern in India and are the second-most common reason for antibiotic use, with infection rates doubling over…

Read More